# Drug-Drug Interaction Study of Vadadustat With Digoxin, Adefovir and Furosemide

> **NCT03801759** · PHASE1 · COMPLETED · sponsor: **Akebia Therapeutics** · enrollment: 62 (actual)

## Conditions studied

- Drug Interaction Potentiation

## Interventions

- **DRUG:** Vadadustat
- **DRUG:** Furosemide
- **DRUG:** Adefovir
- **DRUG:** Digoxin

## Key facts

- **NCT ID:** NCT03801759
- **Lead sponsor:** Akebia Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-20
- **Primary completion:** 2018-09-30
- **Final completion:** 2018-09-30
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2019-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03801759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03801759, "Drug-Drug Interaction Study of Vadadustat With Digoxin, Adefovir and Furosemide". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03801759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*